62,063 Shares of iShares U.S. Pharmaceuticals ETF $IHE Acquired by Virtue Capital Management LLC

Virtue Capital Management LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 62,063 shares of the company’s stock, valued at approximately $6,239,000. iShares U.S. Pharmaceuticals ETF comprises approximately 0.8% of Virtue Capital Management LLC’s portfolio, making the stock its 27th biggest holding. Virtue Capital Management LLC owned about 0.41% of iShares U.S. Pharmaceuticals ETF at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Sunbelt Securities Inc. grew its holdings in iShares U.S. Pharmaceuticals ETF by 14.3% in the first quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock valued at $83,000 after purchasing an additional 120 shares during the period. Root Financial Partners LLC increased its position in iShares U.S. Pharmaceuticals ETF by 36.5% during the first quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock worth $60,000 after purchasing an additional 186 shares during the last quarter. Corient Private Wealth LLC raised its stake in iShares U.S. Pharmaceuticals ETF by 3.1% during the fourth quarter. Corient Private Wealth LLC now owns 6,506 shares of the company’s stock worth $552,000 after purchasing an additional 198 shares during the period. Balance Wealth Partners LLC purchased a new position in iShares U.S. Pharmaceuticals ETF during the third quarter worth approximately $42,000. Finally, NewEdge Advisors LLC raised its stake in iShares U.S. Pharmaceuticals ETF by 45.1% during the first quarter. NewEdge Advisors LLC now owns 1,397 shares of the company’s stock worth $121,000 after purchasing an additional 434 shares during the period.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of IHE opened at $107.61 on Monday. The firm has a market cap of $1.61 billion, a PE ratio of 17.75 and a beta of 0.47. The company’s fifty day moving average is $102.41 and its two-hundred day moving average is $94.74. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $74.93 and a fifty-two week high of $109.43.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.